OIS Israel Agenda 2022
Day 1 | Wednesday, November 09, 2022
14:30 - 14:35
Welcome and Opening Remarks
Daphne Haim-Langford, PhD, Chairperson, Founder & CEO - Tarsier Pharma
14:35 - 15:00
Ophthalmic Market Overview
Keynote Speaker:
Kristen Kluska, Managing Director, Biotechnology Equity Research Analyst - Cantor Fitzgerald
15:00 - 15:45
Company Presentations: Spotlight on Anterior Segment
Moderator:
Robert Rothman, MD, Co-Founder and Managing Member - InFocus Capital Partners / Partner, OCLI/Glaucoma Consultants of Long Island
15:00 - BELKIN Vision | Daria Lemann-Blumenthal, CEO
15:06 - Sanoculis | Nir Israeli, CEO
15:12 - EyeMed Technologies Ltd. | Nir Shimoni, CEO
15:18 - EyeYon Medical | Nahum Ferera, CEO
15:24 - Samsara Vision | Thomas Ruggia, President & CEO
15:30 - CorNeat Vision | Almog Aley-Raz, CEO & VP R&D
15:36 - Nano-Drops | David Smadja, CEO
15:45 - 16:15
KOL Panel Discussion
Moderator:
Dr. Ron Neumann, Chief Medical Officer - BioLight Life Sciences Ltd.
Panelists:
Jeff Goldberg, MD, PhD, Professor and Chair of Ophthalmology - Byers Eye Institute, Stanford University
Itay Chowers, MD, PhD, Director of the Department of Ophthalmology - Hadassah University Medical Center
Anat Loewenstein, MD, PhD, Chair, Department of Ophthalmology - Tel Aviv Medical Center
Irit Bachar, MD, MHA, Chair, Department of Ophthalmology - Rabin Medical Center
David Zadok, MD, MHA, Chair, Department of Ophthalmology - Shaare Zedek Medical Center
16:15 - 16:30
Networking Break
16:30 - 17:10
Company Presentations: Spotlight on Pharma
Moderator:
Daria Lemann-Blumenthal, CEO - BELKIN Vision
16:30 - ELGAN Pharma | Miki Olshansky, Founder & CEO
16:36 - Orasis Pharmaceuticals | Elad Kedar, CEO
16:42 - Glint Pharmaceuticals | Chris Adams, CEO
16:48 - Ocuphire Pharma | Anat Loewenstein, MD, PhD
16:54 - APX Ophthalmology Ltd | Eliahu Eliachar, CEO
17:00 - Tarsier Pharma | Ruti Friedel, Business Development & Comminity Manager
17:10 - 17:55
Investors Panel Discussion
Moderator:
Yaacov Michlin, CEO - BioLight Life Sciences Ltd.
Panelists:
Michal Geva, Co-Founder & Managing Partner - TriVentures
Robert Rothman, MD, Co-Founder and Managing Member - InFocus Capital Partners / Partner - OCLI/Glaucoma Consultants of Long Island
Wang Limin, PhD, Regional General Manager - Rimonci
Dan Teleman, Executive Partner - Israel Biotech Fund
Ronen Bezalel, Partner - Meitar Law Offices
OIS Israel Agenda 2022
Day 2 | Thursday, November 10, 2022
14:00 - 14:20
Special talk with industry leaders
Hoster by:
Robert Rothman, MD, Co-Founder and Managing Member - InFocus Capital Partners
14:20 - 15:00
Company Presentations: Spotlight on Digital and Diagnostics
Moderator:
Nahum Ferera, CEO & Co-Founder - EyeYon Medical
14:20 - DiagnosTear | Shimon Gross, PhD, CEO
14:26 - MIKAJAKI | Jacky Hochner, SVP & Co-Founde
14:32 - Peripherex | Jeff Goldberg, PhD, Founder and CTO
14:38 - NovaSight Ltd. | Ran Yam, CEO
14:44 - REVITALVISION | Yair Yahav, CEO
14:50 - Blink Energy | Yariv Baron, OD, CEO
15:00 - 15:20
Networking Break
15:20 - 15:40
Award Ceremony - For the winning early-stage presenting company
15:40 - 16:25
Company Presentations: Spotlight on Drug Delivery & Retina
Moderator:
Anat Loewenstein, MD, PhD, Chair, Department of Ophthalmology - Tel Aviv Medical Center
15:40 - EyeYon Medical | Anat Lemza, Senior Product Manager
15:46 - Eximore | Eyal Sheetrit, CEO
15:52 - Everads Therapy Ltd. | Moshe Weinstein, CEO
15:58 - Vi-Sci Ltd | Yoni Manor, PhD, CEO
16:04 - Annexin Pharmaceuticals | Anna Frostegaard, Chief Scientific & Medical Officer
16:10 - BioChange | Ishay Attar, Founder & CEO
16:16 - Precise Bio | Aryeh Batt, CEO & Co-Founder
16:25 - 16:45
Itay Mayer, VP, Managing Director Vision - Lumenis
16:45 - 17:05
Naama Hammel, MD, Clinical Research Scientist - Google Health
17:05 - 17:30
Fireside Chat with: Robert Rothman, MD, Co-Founder and Managing Member - InFocus Capital Partners
Interviewing:
Itay Mayer & Dr. Naama Hammel